Total Payments
$3,496
2024 Payments
$29.89
Companies
37
Transactions
222
Medicare Patients
8,968
Medicare Billing
$853,962
Payment Breakdown by Category
Food & Beverage$3,435 (98.2%)
Education$61.86 (1.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,435 | 219 | 98.2% |
| Education | $61.86 | 3 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,090 | 65 | $0 (2021) |
| PFIZER INC. | $389.42 | 22 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $274.97 | 19 | $0 (2021) |
| Lilly USA, LLC | $233.88 | 13 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $220.52 | 17 | $0 (2019) |
| Amgen Inc. | $176.35 | 10 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $99.98 | 8 | $0 (2023) |
| Indivior Inc. | $90.49 | 6 | $0 (2024) |
| Allergan, Inc. | $88.05 | 6 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $79.34 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $29.89 | 2 | Indivior Inc. ($15.50) |
| 2023 | $87.07 | 5 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($24.59) |
| 2022 | $27.77 | 2 | Xeris Pharmaceuticals, Inc. ($14.76) |
| 2021 | $229.93 | 13 | Novo Nordisk Inc ($202.02) |
| 2020 | $148.56 | 6 | Lilly USA, LLC ($97.47) |
| 2019 | $530.15 | 36 | Novo Nordisk Inc ($240.79) |
| 2018 | $1,077 | 61 | Novo Nordisk Inc ($366.68) |
| 2017 | $1,366 | 97 | Novo Nordisk Inc ($280.26) |
All Payment Transactions
222 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/29/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Diabetes | ||||||
| 08/22/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: OUD | ||||||
| 10/04/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Diabetes | ||||||
| 08/30/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: NEUROSCIENCE | ||||||
| 07/27/2023 | Supernus Pharmaceuticals, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 06/29/2023 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Endocrinology | ||||||
| 06/28/2023 | Otsuka Pharmaceutical Development & Commercialization, Inc. | REXULTI (Drug) | Education | In-kind items and services | $24.59 | General |
| Category: PSYCHIATRY | ||||||
| 06/09/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Bone Health | ||||||
| 05/03/2022 | Xeris Pharmaceuticals, Inc. | GVOKE PFS (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Diabetes | ||||||
| 11/12/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $9.73 | General |
| Category: Diabetes | ||||||
| 11/02/2021 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $3.07 | General |
| Category: Obesity | ||||||
| 10/14/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $4.98 | General |
| Category: Diabetes | ||||||
| 09/22/2021 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $4.98 | General |
| Category: Obesity | ||||||
| 09/16/2021 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $8.27 | General |
| 08/02/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $8.40 | General |
| Category: Diabetes | ||||||
| 06/17/2021 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $122.57 | General |
| Category: Obesity | ||||||
| 05/18/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $8.25 | General |
| Category: Diabetes | ||||||
| 04/15/2021 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $10.55 | General |
| Category: Diabetes | ||||||
| 03/09/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: Diabetes | ||||||
| 02/25/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $8.85 | General |
| Category: Diabetes | ||||||
| 02/05/2021 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Neuroscience | ||||||
| 02/04/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/19/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2020 | Amgen Inc. | Aimovig (Biological), Otezla, Repatha | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Neuroscience | ||||||
| 02/20/2020 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $78.61 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,878 | 2,927 | $380,660 | $174,807 |
| 2022 | 16 | 2,171 | 3,657 | $481,285 | $221,328 |
| 2021 | 18 | 2,399 | 3,940 | $511,678 | $240,023 |
| 2020 | 18 | 2,520 | 4,337 | $429,496 | $217,804 |
Total Patients
8,968
Total Services
14,861
Medicare Billing
$853,962
Procedure Codes
67
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 310 | 835 | $154,475 | $69,818 | 45.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 307 | 307 | $58,330 | $37,276 | 63.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 225 | 448 | $67,200 | $24,375 | 36.3% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 316 | 316 | $39,500 | $16,996 | 43.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 155 | 179 | $17,900 | $6,814 | 38.1% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 13 | 115 | $12,075 | $5,629 | 46.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 306 | 306 | $9,180 | $5,196 | 56.6% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 20 | 20 | $5,800 | $2,911 | 50.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $5,520 | $2,085 | 37.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 50 | 149 | $5,215 | $1,386 | 26.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 43 | 43 | $1,505 | $1,230 | 81.7% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 39 | 39 | $1,755 | $797.94 | 45.5% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 40 | 47 | $705.00 | $233.56 | 33.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 12 | 15 | $225.00 | $33.00 | 14.7% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 19 | 85 | $1,275 | $27.72 | 2.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 341 | 969 | $179,265 | $79,289 | 44.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 312 | 312 | $59,280 | $38,479 | 64.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 408 | 759 | $75,900 | $31,649 | 41.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 212 | 473 | $70,950 | $26,725 | 37.7% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 321 | 321 | $40,125 | $18,168 | 45.3% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 17 | 164 | $17,220 | $8,331 | 48.4% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 319 | 319 | $9,570 | $5,420 | 56.6% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 21 | 23 | $6,670 | $3,580 | 53.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 12 | 13 | $5,135 | $2,741 | 53.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 59 | 59 | $2,065 | $1,589 | 77.0% |
About Dr. Brandon Houk, MD
Dr. Brandon Houk, MD is a Addiction Medicine healthcare provider based in Elizabethtown, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/21/2008. The National Provider Identifier (NPI) number assigned to this provider is 1518143577.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brandon Houk, MD has received a total of $3,496 in payments from pharmaceutical and medical device companies, with $29.89 received in 2024. These payments were reported across 222 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($3,435).
As a Medicare-enrolled provider, Houk has provided services to 8,968 Medicare beneficiaries, totaling 14,861 services with total Medicare billing of $853,962. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Ad
Practice Information
- Specialty Addiction Medicine
- Other Specialties Internal Medicine
- Location Elizabethtown, KY
- Active Since 01/21/2008
- Last Updated 11/05/2025
- Taxonomy Code 207RA0401X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1518143577
Products in Payments
- Tresiba (Drug) $318.76
- Ozempic (Drug) $292.49
- FARXIGA (Drug) $244.28
- Victoza (Drug) $216.07
- Trintellix (Drug) $136.33
- ELIQUIS (Drug) $129.45
- Wegovy (Drug) $127.55
- LYRICA (Drug) $105.10
- LONHALA MAGNAIR (Drug) $104.57
- CHANTIX (Drug) $89.90
- Prolia (Biological) $89.45
- VIAGRA (Drug) $64.97
- UTIBRON (Drug) $63.81
- Levemir (Drug) $58.23
- JANUVIA (Drug) $53.37
- TRULICITY (Drug) $52.86
- BROVANA (Drug) $52.14
- STIOLTO (Drug) $48.19
- SUBOXONE SUBLINGUAL FILM (Drug) $47.63
- Repatha (Biological) $43.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.